GILDER GAGNON HOWE & CO LLC

Position in PCVX — Vaxcyte, Inc.

CIK 902464 New York, NY

Position in PCVX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$991,930

-$6,109 QoQ

Shares Held

17,064

-0.6% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#164

of 329 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GILDER GAGNON HOWE & CO LLC holds $353,222,516 across 21 Biotechnology names. PCVX ranks #18 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	269,051	$80,992,422
2	NKTR	Nektar Therapeutics	600,873	$41,946,944
3	BBIO	BridgeBio Pharma, Inc.	548,926	$40,884,008
4	ARQT	Arcutis Biotherapeutics, Inc.	1,313,211	$34,432,392
5	CYTK	Cytokinetics Inc	400,245	$34,096,871
6	KYMR	Kymera Therapeutics, Inc.	229,053	$26,265,507
7	QURE	uniQure N.V.	530,979	$24,456,892
8	MDGL	Madrigal Pharmaceuticals, Inc.	28,573	$15,342,272

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$991,930	17,064	-0.6%	Shares	Sole	2026-08-14
2026-03-31	$998,039	17,175	+6.6%	Shares	Sole	2026-05-15
2025-12-31	$743,269	16,109	-0.2%	Shares	Sole	2026-02-17
2025-09-30	$581,398	16,141	-0.9%	Shares	Sole	2025-11-14
2025-06-30	$529,425	16,285	-0.5%	Shares	Sole	2025-08-14
2025-03-31	$617,715	16,359	-1.2%	Shares	Sole	2025-05-15
2024-12-31	$1,354,783	16,550	+0.3%	Shares	Sole	2025-02-14
2024-09-30	$1,886,369	16,508	-1.9%	Shares	Sole	2024-11-14
2024-06-30	$1,270,908	16,831	-1.4%	Shares	Sole	2024-08-14
2024-03-31	$1,166,598	17,078	-0.1%	Shares	Sole	2024-05-15
2023-12-31	$1,073,942	17,101	-0.0%	Shares	Sole	2024-02-14
2023-09-30	$872,063	17,106	+0.5%	Shares	Sole	2023-11-14
2023-06-30	$850,078	17,022	+25.5%	Shares	Defined	2023-08-14
2023-03-31	$508,528	13,568	-2.0%	Shares	Defined	2023-05-15
2022-12-31	$663,819	13,844	—	Shares	Defined	2023-02-14
No filing history on record for this holder in this stock.